InsidersTradesSigma
Xintela AB: directors' dealings · Finland · FIN-FSA
FI:xintela-abSE0026875932FI·FIN-FSAMcap 215M€Healthcare
Explore the full directors' dealings record of Xintela AB, a listed equity based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, Xintela AB has recorded 4 public disclosures. Market capitalisation: €215.3m. The latest transaction was filed on 9 December 2025 — Purchase. Among the most active insiders: Thomas Eldered. All data is openly available.
4
Insider Decl.
0
Thresholds
€25,695
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.25 €
Analyst consensus
Income statement
Revenue2.3 M€
Gross profit2.3 M€100% margin
Net income−48.6 M€-2128.1% margin
Valuation
Beta2.02
Balance sheet & cash
Market cap215.3 M€
Total debt20.0 M€
Free Cash Flow−41.6 M€
Profitability & ownership
ROA-108.4%
% insiders9.4%
% institutions48.2%
Last declaration on 9 December 2025
Declarations4 total
Executives●Purchase15FIN-FSA
€7,130300,000 shares@ €0.02380.0033% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003U534-1·
Ideal exit: 5 Sept 2026 (T+270)
Executives●Other7FIN-FSA
0279,245,785 shares0
Teckningsrätt/Uniträtt
FI:A003U530-1·
Executives●Purchase15FIN-FSA
€13,666577,000 shares@ €0.02370.0063% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003U518-1·
Ideal exit: 1 Sept 2026 (T+270)
Executives●Purchase27FIN-FSA
€4,899206,820 shares@ €0.02370.0023% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003U477-1·
Ideal exit: 1 Sept 2026 (T+270)
4 of 4 declarations